← Leaderboards
Mark J Zylka
Univ Of North Carolina Chapel Hill
$33,948,391
Attributed
$37,932,720
Total exposure
20
Grants
19
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.9M · FY2007–25$5M$3.8M$2.5M$1.3M$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$39,954,220 · 21
By mechanism
R01$18,380,691 · 8
R35$5,964,210 · 1
P30$5,046,261 · 5
DP1$3,792,400 · 1
T32$3,655,783 · 1
UG3$1,508,248 · 1
Top collaborators
- Benjamin D Philpot12 shared
- Juan Song2 shared
- Michael J. Mcconnell1 shared
Most similar at Univ Of North Carolina Chapel Hill
Same institution · by research overlap
- Nathaniel A Sowa$113,812
- Benjamin D Philpot$13,874,681
- Michael S Sidorov$1,670,012
- Adam Hantman$4,244,404
- Joseph Morrissey$2,834,072
Others in their field
Top investigators on “Neurons”
- Hongkui Zeng · Allen Institute$106,358,289
- Eric Martin McDade · Washington University$94,632,845
- Ed Lein · Allen Institute$90,858,363
- Randall J Bateman · Washington University$65,841,935
- John Morris · Washington University$65,018,684
- Paul S. Aisen · Cognition Therapeutics, Inc.$58,570,460
Research focus
NeuronsGenesMouse ModelBrainResearch PersonnelIn VivoMutationFutureNeurosciencesBehavioralAutism Spectrum DisorderTrainingNeurodevelopmental DisorderCellsBaseGeneticPainLinkAffectEffective TherapySymptomsAllelesAnimal ModelAnalgesics
Grant awards (89)
Genome editor therapy for Angelman syndrome$1,508,248
UG3 · FY2025 · NS · contact PI
Environmental-use chemicals that target pathways linked to autism and other neurodevelopmental disorders$852,030
R35 · FY2025 · ES · contact PI
Targeted high-fidelity integration of DNA elements into the genome$603,457
R01 · FY2025 · NS · contact PI
Neuroscience Predoctoral Training at UNC-Chapel Hill$482,469
T32 · FY2025 · NS · contact PI
Luminescence-based biosensor to non-invasively measure UBE3A activity in the brain$233,250
R21 · FY2025 · NS · contact PI
Environmental-use chemicals that target pathways linked to autism and other neurodevelopmental disorders$852,030
R35 · FY2024 · ES · contact PI
Development of a deep neural network to measure spontaneous pain from mouse facial expressions$364,782
R01 · FY2024 · NS · contact PI
Neuroscience Predoctoral Training at UNC-Chapel Hill$215,923
T32 · FY2024 · NS · contact PI
Environmental-use chemicals that target pathways linked to autism and other neurodevelopmental disorders$852,030
R35 · FY2023 · ES · contact PI
UBE3A gain-of-function and parent-of-origin influence on neurodevelopmental phenotypes$648,365
R01 · FY2023 · MH · contact PI
CRISPR/Cas9-based gene therapy for Angelman syndrome$537,260
R01 · FY2023 · NS · contact PI
Neuroscience Predoctoral Training at UNC-Chapel Hill$535,395
T32 · FY2023 · NS · contact PI
Development of a deep neural network to measure spontaneous pain from mouse facial expressions$376,135
R01 · FY2023 · NS · contact PI
Development of a deep neural network to measure spontaneous pain from mouse facial expressions$39,687
R01 · FY2023 · NS · contact PI
Environmental-use chemicals that target pathways linked to autism and other neurodevelopmental disorders$852,030
R35 · FY2022 · ES · contact PI
UBE3A gain-of-function and parent-of-origin influence on neurodevelopmental phenotypes$648,365
R01 · FY2022 · MH · contact PI
CRISPR/Cas9-based gene therapy for Angelman syndrome$540,720
R01 · FY2022 · NS · contact PI
Neuroscience Predoctoral Training at UNC-Chapel Hill$525,222
T32 · FY2022 · NS · contact PI
Development of a deep neural network to measure spontaneous pain from mouse facial expressions$376,135
R01 · FY2022 · NS · contact PI
UNC Neuroscience Center Research Cores$155,500
P30 · FY2022 · NS · contact PI
UNC Neuroscience Center Research Cores: Administrative$51,834
P30 · FY2022 · NS · contact PI
UNC Neuroscience Center Research Cores: Microscopy$51,833
P30 · FY2022 · NS · contact PI
UNC Neuroscience Center Research Cores: Bioinformatics$51,833
P30 · FY2022 · NS · contact PI
Environmental-use chemicals that target pathways linked to autism and other neurodevelopmental disorders$852,030
R35 · FY2021 · ES · contact PI
UBE3A gain-of-function and parent-of-origin influence on neurodevelopmental phenotypes$671,160
R01 · FY2021 · MH · contact PI
CRISPR/Cas9-based gene therapy for Angelman syndrome$586,106
R01 · FY2021 · NS · contact PI
Neuroscience Predoctoral Training at UNC-Chapel Hill$492,489
T32 · FY2021 · NS · contact PI
UNC Neuroscience Center Research Cores$466,500
P30 · FY2021 · NS · contact PI
Development of a deep neural network to measure spontaneous pain from mouse facial expressions$362,249
R01 · FY2021 · NS · contact PI
UNC Neuroscience Center Research Cores: Microscopy$254,304
P30 · FY2021 · NS · contact PI
UNC Neuroscience Center Research Cores: Bioinformatics$184,865
P30 · FY2021 · NS · contact PI
UNC Neuroscience Center Research Cores: Administrative$27,331
P30 · FY2021 · NS · contact PI
Environmental-use chemicals that target pathways linked to autism and other neurodevelopmental disorders$852,030
R35 · FY2020 · ES · contact PI
UBE3A gain-of-function and parent-of-origin influence on neurodevelopmental phenotypes$700,632
R01 · FY2020 · MH · contact PI
CRISPR/Cas9-based gene therapy for Angelman syndrome$569,876
R01 · FY2020 · NS · contact PI
Neuroscience Predoctoral Training at UNC-Chapel Hill$486,916
T32 · FY2020 · NS · contact PI
UNC Neuroscience Center Research Cores$466,500
P30 · FY2020 · NS · contact PI
Development of a deep neural network to measure spontaneous pain from mouse facial expressions$364,998
R01 · FY2020 · NS · contact PI
UNC Neuroscience Center Research Cores: Microscopy$244,423
P30 · FY2020 · NS · contact PI
UNC Neuroscience Center Research Cores: Bioinformatics$181,930
P30 · FY2020 · NS · contact PI
UNC Neuroscience Center Research Cores: Administrative$40,147
P30 · FY2020 · NS · contact PI
Environmental-use chemicals that target pathways linked to autism and other neurodevelopmental disorders$852,030
R35 · FY2019 · ES · contact PI
UBE3A gain-of-function and parent-of-origin influence on neurodevelopmental phenotypes$684,940
R01 · FY2019 · MH · contact PI
CRISPR/Cas9-based gene therapy for Angelman syndrome$569,876
R01 · FY2019 · NS · contact PI
Neuroscience Predoctoral Training at UNC-Chapel Hill$528,731
T32 · FY2019 · NS · contact PI
UNC Neuroscience Center Research Cores$466,500
P30 · FY2019 · NS · contact PI
UNC Neuroscience Center Research Cores: Microscopy$254,303
P30 · FY2019 · NS · contact PI
Single cell transcriptional analysis of spinal cord in a neuropathic pain model$187,936
R21 · FY2019 · NS · contact PI
UNC Neuroscience Center Research Cores: Bioinformatics$184,868
P30 · FY2019 · NS · contact PI
UNC Neuroscience Center Research Cores: Administrative$27,329
P30 · FY2019 · NS · contact PI
Transcription-associated DNA damage and neurodegeneration$708,630
R56 · FY2018 · AG · contact PI
UNC Neuroscience Center Research Cores$466,500
P30 · FY2018 · NS · contact PI
Neuroscience Predoctoral Training at UNC-Chapel Hill$388,638
T32 · FY2018 · NS · contact PI
UNC Neuroscience Center Research Cores: Microscopy$254,303
P30 · FY2018 · NS · contact PI
Single cell transcriptional analysis of spinal cord in a neuropathic pain model$226,811
R21 · FY2018 · NS · contact PI
UNC Neuroscience Center Research Cores: Bioinformatics$184,868
P30 · FY2018 · NS · contact PI
UNC Neuroscience Center Research Cores: Administrative$27,329
P30 · FY2018 · NS · contact PI
The Elongation Hypothesis of Autism$760,000
DP1 · FY2017 · ES · contact PI
Lipid kinase regulation of pain signaling and sensitization$329,876
R01 · FY2017 · NS · contact PI
Identification of candidate environmental risks for autism$250,000
R56 · FY2017 · ES · contact PI
The Elongation Hypothesis of Autism$760,000
DP1 · FY2016 · ES · contact PI
Epigenetic Regulation of Ube3a as a Treatment for Angelman Syndrome$591,194
R01 · FY2016 · MH
Lipid kinase regulation of pain signaling and sensitization$329,876
R01 · FY2016 · NS · contact PI
The Elongation Hypothesis of Autism$760,000
DP1 · FY2015 · ES · contact PI
Epigenetic Regulation of Ube3a as a Treatment for Angelman Syndrome$589,741
R01 · FY2015 · MH
Lipid kinase regulation of pain signaling and sensitization$329,876
R01 · FY2015 · NS · contact PI
The Elongation Hypothesis of Autism$752,400
DP1 · FY2014 · ES · contact PI
Epigenetic Regulation of Ube3a as a Treatment for Angelman Syndrome$607,649
R01 · FY2014 · MH
Lipid kinase regulation of pain signaling and sensitization$326,577
R01 · FY2014 · NS · contact PI
The Elongation Hypothesis of Autism$760,000
DP1 · FY2013 · ES · contact PI
Harnessing ectonucleotidases to treat chronic pain$708,206
R01 · FY2013 · NS · contact PI
Epigenetic Regulation of Ube3a as a Treatment for Angelman Syndrome$678,041
R01 · FY2013 · MH
Lipid kinase regulation of pain signaling and sensitization$329,876
R01 · FY2013 · NS · contact PI
BAC Technology$180,011
P30 · FY2013 · NS · contact PI
Epigenetic Regulation of Ube3a as a Treatment for Angelman Syndrome$94,681
R01 · FY2013 · MH
Harnessing ectonucleotidases to treat chronic pain$730,301
R01 · FY2012 · NS · contact PI
Epigenetic Regulation of Ube3a as a Treatment for Angelman Syndrome$614,344
R01 · FY2012 · MH
BAC Technology$186,539
P30 · FY2012 · NS · contact PI
Epigenetic Regulation of Ube3a as a Treatment for Angelman Syndrome$32,524
R01 · FY2012 · MH
Harnessing ectonucleotidases to treat chronic pain$730,500
R01 · FY2011 · NS · contact PI
Harnessing ectonucleotidases to treat chronic pain$730,702
R01 · FY2010 · NS · contact PI
Biochemical Modulation of Nociceptive Circuits$313,921
R01 · FY2010 · NS · contact PI
BAC Technology$264,263
P30 · FY2010 · NS · contact PI
Harnessing ectonucleotidases to treat chronic pain$716,790
R01 · FY2009 · NS · contact PI
Biochemical Modulation of Nociceptive Circuits$317,091
R01 · FY2009 · NS · contact PI
BAC Technology$186,539
P30 · FY2009 · NS · contact PI
Biochemical Modulation of Nociceptive Circuits$317,091
R01 · FY2008 · NS · contact PI
BAC Technology$185,909
P30 · FY2008 · NS · contact PI
Biochemical Modulation of Nociceptive Circuits$317,091
R01 · FY2007 · NS · contact PI